Based on our results on increased disease risk for HF patient carriers of the combined GSTA1/GSTP1 variant genotype, it might be speculated that the impaired GSTP1:JNK interaction in CAD [37] could be further modified in patient carriers of the combined GSTA1/GSTP1 risk-associated genotype. The gene discussed is MAPK8; the disease is coronary artery disorder.